Should Medicare pay for Aduhelm? kevinmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kevinmd.com Daily Mail and Mail on Sunday newspapers.
email article In June, the FDA approved aducanumab (Aduhelm) to treat patients with Alzheimer s disease using the agency s accelerated approval pathway, despite significant concerns about the evidence regarding the drug s safety and effectiveness. The agency s approval decision contradicted the recommendations of its own advisory committee, which voted overwhelmingly against the evidence presented in support of the drug. Soon after approval, three members of the committee resigned in protest. In his resignation letter, Aaron Kesselheim, MD, JD, MPH, of the Harvard School of Medicine, called the aducanumab decision probably the worst drug approval decision in recent U.S. history. Tia Powell, MD, director of the Montefiore Einstein Center for Bioethics, called the FDA decision a failure of scientific integrity.
To save itself, might Medicare deny coverage of controversial new Alzheimer's drug? - News mcknights.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mcknights.com Daily Mail and Mail on Sunday newspapers.
A new phase of the US immunization campaign has begun, with supply now expected to exceed demand. Public-health experts are debating whether vaccine mandates for some groups would help or hurt. Some organizations, like a major Houston health system, are requiring the shot for their employees. The US vaccination campaign is entering a new phase, marked by excess supply of shots. And public-health experts, bioethicists, and doctors are debating whether or not mandating the COVID-19 vaccine would be helpful or harmful. The arguments for and against mandates are shaping up to be a signature element of this next phase of the immunization campaign, as the key challenge in reaching herd immunity shifts from supply to demand. And experts are split on whether or not it s time to start enacting such requirements, as much of the nation continues to re-open and relax public-health restrictions.
05:31 Advertisement Overall, in conversations with five bioethicists, doctors, and public-health experts, Insider found an array of opinions on mandates. The most ardent backers say they should be rolled out now. Other supporters say they make sense in the next few months. Other experts warned the mandates are a heavy-handed approach that will be harmful at this stage in the rollout. There should be more in education and outreach to hesitant groups before requiring the shot, they say. Art Caplan, a bioethicist at New York University, said he hopes more groups will follow the mandate track. Why are we still battling vaccine hesitancy with one hand behind our back? Caplan told Insider. Let s start to move a mandate through populations that are posing risks to others.
Should the COVID-19 vaccine be mandated? Debate takes center stage, as hospitals, colleges and businesses start requiring the shot. yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Insert future code here > 11-30 to 12-23 Insert future code here > 12-23 to 01-15 Insert future code here > 01-16-2019 to 2-16-2019 Insert future code here > 01-16-2019 to 2-16-2019 Insert future code here > 2-17-2019 to 3-24-2019 Insert future code here > 3-24-19 to 4-7-2019 Insert future code here > Chicks on the loose Insert future code here > Herb and Veggie Insert future code here > GNO D Ville Insert future code here > Early Bird thu June 4 Insert future code here > Fatehrs Day Insert future code here > Ourdoor Living
Insert future code here > 11-30 to 12-23 Insert future code here > 12-23 to 01-15 Insert future code here > 01-16-2019 to 2-16-2019 Insert future code here > 01-16-2019 to 2-16-2019 Insert future code here > 2-17-2019 to 3-24-2019 Insert future code here > 3-24-19 to 4-7-2019 Insert future code here > Chicks on the loose Insert future code here > Herb and Veggie Insert future code here > GNO D Ville Insert future code here > Early Bird thu June 4 Insert future code here > Fatehrs Day Insert future code here > Ourdoor Living
California s Hospital Crisis: What Lies Ahead As COVID infections and hospitalizations mount in California, ICU availability dropped to zero in Southern and Central California. Demand for hospital care is also outstripping supply in New Mexico. December 21, 2020, 12pm PST | Irvin Dawid Share Robert V Schwemmer We ve been here before in the pandemic. First in the spring in New York City, then the summer in Arizona and South Texas. On December 10, it was New Mexico s turn to activate the crisis standards of care, a protocol for determining who receives treatment, and, as William Haseltine, a former Harvard Medical School and Harvard School of Public Health professor, bluntly told CNN on July 8 regarding the hospital crisis in Arizona:
New in the Should many prescription drugs be available over the counter? The Hastings Center Madison Kilbride, Steven Joffe, and Holly Fernandez Lynch When new drugs are approved by the Food and Drug Administration, the default assumption is that they will be available by prescription only, safe for use exclusively under clinical supervision. The paternalism underlying this default must be interrogated in order to ensure appropriate respect for patient autonomy. Upon closer inspection, prescription requirements are justified when nonprescription status would risk harm to third parties and when a large segment of the population would struggle to exercise their autonomy in using a drug safely and effectively on their own. Although these justifications can support prescription status for many drugs, this article proposes that reversing the FDA s current default to instead begin with a presumption in favor of over?the?counter status is the best way to avoid interference with valid claims of patient autonomy. Under this approach, a range of drug products, including oral contraceptives, statins, and HIV?prevention drugs, could be considered for an OTC switch. The authors are at the Perelman School of Medicine at the University of Pennsylvania.